Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 2.65 is 125% above its 5-year average of -10.52, near the high end of its 5-year range (-21.00–2.65).
150.03% above its 12-month average of -5.30.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.01.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:05:27.678Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
2.65
EARNINGS PER SHARE (EPS) AVG TTM
-5.30
EARNINGS PER SHARE (EPS) AVG 3Y
-10.00
EARNINGS PER SHARE (EPS) AVG 5Y
-10.52
EARNINGS PER SHARE (EPS) AVG 10Y
-16.81
EARNINGS PER SHARE (EPS) AVG 15Y
-12.50
EARNINGS PER SHARE (EPS) AVG 20Y
-10.69
CURRENT VS TTM AVG
+150.03%
CURRENT VS 3Y AVG
+126.51%
CURRENT VS 5Y AVG
+125.20%
CURRENT VS 10Y AVG
+115.77%
CURRENT VS 15Y AVG
+121.20%
CURRENT VS 20Y AVG
+124.78%
Agenus Inc.
Market Cap
$348.55M
Earnings Per Share (EPS)
2.65
TTM Avg
-5.30
3Y Avg
-10.00
5Y Avg
-10.52
Market Cap
$354.48M
Earnings Per Share (EPS)
1.48
TTM Avg
1.49
3Y Avg
2.03
5Y Avg
3.82
Market Cap
$341.50M
Earnings Per Share (EPS)
-3.31
TTM Avg
-3.43
3Y Avg
-2.65
5Y Avg
-2.61
Market Cap
$341.46M
Earnings Per Share (EPS)
-1.18
TTM Avg
-0.80
3Y Avg
-0.80
5Y Avg
-0.72
Market Cap
$357.37M
Earnings Per Share (EPS)
-2.41
TTM Avg
-4.66
3Y Avg
-5.40
5Y Avg
-4.56
Market Cap
$357.44M
Earnings Per Share (EPS)
-0.14
TTM Avg
-0.19
3Y Avg
-0.48
5Y Avg
-0.56
Market Cap
$359.05M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.30
3Y Avg
-1.38
5Y Avg
-1.95
Market Cap
$329.37M
Earnings Per Share (EPS)
-1.58
TTM Avg
-1.99
3Y Avg
-1.86
5Y Avg
-1.78
Market Cap
$328.40M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.40
3Y Avg
-2.02
5Y Avg
-1.91
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agenus Inc. (AGEN) | $348.55M | 2.65 | -5.30 | -10.00 | -10.52 |
| Embecta Corp. (EMBC)vs › | $354.48M | 1.48 | 1.49 | 2.03 | 3.82 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $341.50M | -3.31 | -3.43 | -2.65 | -2.61 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $341.46M | -1.18 | -0.80 | -0.80 | -0.72 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.37M | -2.41 | -4.66 | -5.40 | -4.56 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $357.44M | -0.14 | -0.19 | -0.48 | -0.56 |
| Opus Genetics, Inc. (IRD)vs › | $359.05M | N/A | -1.30 | -1.38 | -1.95 |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | -1.58 | -1.99 | -1.86 | -1.78 |
| C4 Therapeutics, Inc. (CCCC)vs › | $328.40M | -1.00 | -1.40 | -2.02 | -1.91 |
| CapsoVision, Inc. (CV)vs › | $323.01M | -0.63 | -0.48 | -0.42 | -0.42 |
Trailing EPS (TTM)
$2.65
Forward EPS (Est.)
$0.27
P/E Ratio
3.2
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.00 |
| 2024-12-31 | -10.59 |
| 2023-12-31 | -13.75 |
| 2022-12-31 | -15.64 |
| 2021-12-31 | -2.11 |
| 2020-12-31 | -21.00 |
| 2018-12-31 | -28.83 |
| 2017-12-31 | -24.53 |
| 2016-12-31 | -29.17 |
| 2015-12-31 | -22.47 |
| 2014-12-31 | -14.22 |
| 2013-12-31 | -2.21 |
| 2012-12-31 | -0.48 |
| 2011-12-31 | -1.17 |
| 2010-12-31 | -1.36 |
| 2009-12-31 | -2.30 |
| 2008-12-31 | -2.72 |
| 2007-12-31 | -4.75 |
| 2006-12-31 | -6.80 |
| 2005-12-31 | -9.76 |
| 2004-12-31 | -7.54 |
| 2003-12-31 | -10.15 |
| 2002-12-31 | -10.19 |
| 2001-12-31 | -15.68 |
| 2000-12-31 | -11.37 |
| 1999-12-31 | -5.99 |
